Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ilya A. Kadnikov"'
Autor:
Mikhail V. Voronin, Ilya A. Kadnikov, Liana F. Zainullina, Ilya O. Logvinov, Ekaterina R. Verbovaya, Tatyana A. Antipova, Yulia V. Vakhitova, Sergei B. Seredenin
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13061, p 13061 (2021)
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 13061
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 13061
International Journal of Molecular Sciences
The ability of NQO2 to increase the production of free radicals under enhanced generation of quinone derivatives of catecholamines is considered to be a component of neurodegenerative disease pathogenesis. The present study aimed to investigate the n
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-6
Autor:
Yulia V. Vakhitova, Tatiana S. Kalinina, Liana F. Zainullina, Anastasiya Yu. Lusta, Anna V. Volkova, Nikita V. Kudryashov, Tatiana A. Gudasheva, Alexander A. Shimshirt, Ilya A. Kadnikov, Mikhail V. Voronin, Sergei B. Seredenin
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13381, p 13381 (2021)
International Journal of Molecular Sciences; Volume 22; Issue 24; Pages: 13381
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 22; Issue 24; Pages: 13381
International Journal of Molecular Sciences
Induction of BDNF-TrkB signaling is associated with the action mechanisms of conventional and fast-acting antidepressants. GSB-106, developed as a small dimeric dipeptide mimetic of BDNF, was previously shown to produce antidepressant-like effects in
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
Parkinson’s disease (PD) is a progressive neurodegenerative disease with limited treatment options. Therefore, the identification of therapeutic targets is urgently needed. Previous studies have shown that the ligand activation of the sigma-1 chape
Autor:
Dmitry N. Voronkov, Ekaterina R Verbovaya, Ilya A. Kadnikov, Sergei B Seredenin, Mikhail V. Voronin
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 20
International Journal of Molecular Sciences, Vol 21, Iss 7620, p 7620 (2020)
Volume 21
Issue 20
International Journal of Molecular Sciences, Vol 21, Iss 7620, p 7620 (2020)
Previously, we demonstrated that the immediate administration of multitarget anxiolytic afobazole slows down the progression of neuronal damage in a 6-hydroxidodamine (6-OHDA) model of Parkinson&rsquo
s disease due to the activation of chaperone
s disease due to the activation of chaperone
Autor:
Mikhail V. Voronin, Ilya A. Kadnikov
Publikováno v:
Pharmacology Research & Perspectives
Anxiolytic afobazole (5‐Ethoxy‐2‐[2‐(morpholino)‐ethylthio]benzimidazole dihidrochloride) has pronounced ligand properties toward Sigma‐1 receptor (σ1 receptor,SigmaR1) and MT 3 receptors. Our previous work demonstrated that afobazole po